Sound View Wealth Advisors Group LLC Reduces Stock Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Sound View Wealth Advisors Group LLC lessened its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1.0% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,864 shares of the medical equipment provider’s stock after selling 28 shares during the quarter. Sound View Wealth Advisors Group LLC’s holdings in Intuitive Surgical were worth $1,495,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Berbice Capital Management LLC acquired a new stake in Intuitive Surgical in the 4th quarter worth about $26,000. BankPlus Trust Department acquired a new stake in Intuitive Surgical in the 4th quarter worth about $28,000. Kohmann Bosshard Financial Services LLC acquired a new stake in Intuitive Surgical in the 4th quarter worth about $31,000. MidAtlantic Capital Management Inc. acquired a new stake in Intuitive Surgical in the 3rd quarter worth about $33,000. Finally, Decker Retirement Planning Inc. acquired a new stake in Intuitive Surgical in the 4th quarter worth about $36,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Insiders Place Their Bets

In other Intuitive Surgical news, Director Amal M. Johnson sold 4,635 shares of Intuitive Surgical stock in a transaction that occurred on Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the sale, the director now directly owns 12,275 shares in the company, valued at $6,955,015. The trade was a 27.41 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Jamie Samath sold 270 shares of Intuitive Surgical stock in a transaction that occurred on Tuesday, December 10th. The stock was sold at an average price of $540.15, for a total value of $145,840.50. Following the sale, the chief financial officer now owns 8,757 shares in the company, valued at $4,730,093.55. This represents a 2.99 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 13,579 shares of company stock worth $7,756,844 in the last three months. 0.90% of the stock is owned by insiders.

Intuitive Surgical Stock Performance

Intuitive Surgical stock opened at $518.26 on Monday. The stock’s 50 day moving average price is $571.36 and its 200 day moving average price is $531.85. The firm has a market capitalization of $184.59 billion, a PE ratio of 80.85, a price-to-earnings-growth ratio of 5.85 and a beta of 1.43. Intuitive Surgical, Inc. has a one year low of $364.17 and a one year high of $616.00.

Wall Street Analysts Forecast Growth

A number of analysts have issued reports on ISRG shares. Leerink Partners raised their price target on Intuitive Surgical from $490.00 to $548.00 in a research note on Monday, January 27th. CICC Research started coverage on Intuitive Surgical in a research note on Monday, January 27th. They issued a “neutral” rating and a $550.00 price target on the stock. Wells Fargo & Company raised their price target on Intuitive Surgical from $630.00 to $687.00 and gave the stock an “overweight” rating in a research note on Friday, January 24th. Bernstein Bank lifted their price objective on Intuitive Surgical from $655.00 to $700.00 and gave the company an “overweight” rating in a research note on Monday, January 27th. Finally, Piper Sandler reaffirmed an “overweight” rating and issued a $670.00 price objective (up from $538.00) on shares of Intuitive Surgical in a research note on Friday, January 24th. One research analyst has rated the stock with a sell rating, four have given a hold rating and sixteen have assigned a buy rating to the company’s stock. According to data from MarketBeat, Intuitive Surgical has an average rating of “Moderate Buy” and an average target price of $613.10.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.